PDGFRB and prostate cancer: The percentages of NT5E+, TNC+, and PDGFRβ+ cells did not significantly vary between stroma adjacent to benign prostate glands and prostate cancer (Figures 4A,B, 5A,B, and 6A,B, and supplementary material, Table S5).